Glycotope GmbH

Industry · 9 registered clinical trials.

Status	Trial	Phase	Started
Completed	Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid Tumors Solid Tumor, Adult	Phase 1	2017-11-02
Completed	CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer Carcinoma, Squamous Cell of Head and Neck	Phase 2	2014-02-01
Completed	PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer Ovarian Epithelial Cancer Recurrent, Fallopian Tube Cancer, Primary Peritoneal Cancer	Phase 2	2013-09-01
Completed	Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f® Infertility	Phase 2	2013-01-08
Completed	Multiple Dose FSH-GEX(TM) in Healthy Volunteers Female Infertility	Phase 1	2011-10-01
Completed	TrasGEX™: Phase 1 Study in Cancer Patients Solid Tumors	Phase 1	2011-07-01
Completed	Single Dose FSH-GEX™ in Healthy Volunteers Female Infertility	Phase 1	2011-04-01
Completed	CetuGEX™: Phase 1 Study in Cancer Patients Solid Tumors	Phase 1	2010-08-01
Completed	PankoMab-GEX™: Phase 1 Dose Escalation Study Solid Tumors	Phase 1	2009-11-01